User profiles for Themoula Charalampous
 | Themoula CharalampousVerified email at kcl.ac.uk Cited by 4021 |
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection
The gold standard for clinical diagnosis of bacterial lower respiratory infections (LRIs) is
culture, which has poor sensitivity and is too slow to guide early, targeted antimicrobial therapy. …
culture, which has poor sensitivity and is too slow to guide early, targeted antimicrobial therapy. …
[HTML][HTML] Rapid inference of antibiotic resistance and susceptibility by genomic neighbour typing
…, KC Ma, DR MacFadden, T Charalampous… - Nature …, 2020 - nature.com
Surveillance of drug-resistant bacteria is essential for healthcare providers to deliver
effective empirical antibiotic therapy. However, traditional molecular epidemiology does not …
effective empirical antibiotic therapy. However, traditional molecular epidemiology does not …
[HTML][HTML] Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study
…, X Wang, F Shah, SF Rapport, T Charalampous… - Respiratory …, 2019 - Springer
… Themoula Charalampous received financial support from ONT for attending an international
conference.Dr. Themoula Charalampous received financial support from ONT for attending …
conference.Dr. Themoula Charalampous received financial support from ONT for attending …
[HTML][HTML] Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort …
…, L Snell, A Patel, T Charalampous… - The Lancet Infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant was first detected in England in March,
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
2021. It has since rapidly become the predominant lineage, owing to high transmissibility. …
[PDF][PDF] Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
…, W Fuller, C Bresner, LB Snell, T Charalampous… - Cell, 2021 - cell.com
Global dispersal and increasing frequency of the SARS-CoV-2 spike protein variant D614G
are suggestive of a selective advantage but may also be due to a random founder effect. We …
are suggestive of a selective advantage but may also be due to a random founder effect. We …
[HTML][HTML] Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study
…, LB Snell, A Patel, T Charalampous… - The Lancet Public …, 2021 - thelancet.com
Background The SARS-CoV-2 variant B.1.1.7 was first identified in December, 2020, in
England. We aimed to investigate whether increases in the proportion of infections with this …
England. We aimed to investigate whether increases in the proportion of infections with this …
Rapid diagnosis of lower respiratory infection using nanopore-based clinical metagenomics
T Charalampous, H Richardson, GL Kay, R Baldan… - BioRxiv, 2018 - biorxiv.org
Lower respiratory infections (LRIs) accounted for three million deaths worldwide in 2016, the
leading infectious cause of mortality. The “gold standard” for investigation of bacterial LRIs …
leading infectious cause of mortality. The “gold standard” for investigation of bacterial LRIs …
[HTML][HTML] Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
…, SR Hallett, S Pickering, T Charalampous… - Nature …, 2021 - nature.com
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …
[HTML][HTML] Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre …
…, A Patel, MTK Ik, B Patel, T Charalampous… - The Lancet …, 2021 - thelancet.com
Background Lateral flow devices (LFDs) for rapid antigen testing are set to become a cornerstone
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …
of SARS-CoV-2 mass community testing, although their reduced sensitivity compared …
[PDF][PDF] The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
We identify amino acid variants within dominant SARS-CoV-2 T cell epitopes by interrogating
global sequence data. Several variants within nucleocapsid and ORF3a epitopes have …
global sequence data. Several variants within nucleocapsid and ORF3a epitopes have …
